Awakn Life Sciences Corp. (AWKN.NE)
Stock analysis · NEO · Healthcare · Biotechnology
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
2.85
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A
Awakn Life Sciences Corp. (AWKN.NE) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Most Recent
Dec 14, 2023
EPS $-0.02 vs est. $-0.03
Beat by $0.01
Proprietary Signals
About Awakn Life Sciences Corp.
Awakn Life Sciences Corp., a biotechnology firm headquartered in Toronto, Canada, specializes in the discovery, development, and provision of psychedelic therapies. Its mission is to address addiction and other mental health challenges throughout the United Kingdom and across Europe.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap